Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Earnings

Organto Foods Announces Third Quarter 2025 Financial Results

OGO · Price

Executive Summary

  • Organto Foods reported record third‑quarter sales of $15.1 M (↑189% YoY) and nine‑month sales of $45.9 M (↑222% YoY).
  • Despite strong revenue growth, the company posted a net loss of $2.0 M for Q3 and $9.6 M for the nine‑month period, driven by derivative losses and debt‑settlement costs.
  • The balance sheet was materially strengthened: cash rose to $8.8 M (from $0.3 M) and working capital improved to $8.6 M (from –$14.6 M).

Key Details

  • Quarterly Sales: $15.1 M, up 189% YoY; largest Q3 sales in company history.
  • Quarterly Gross Profit: $1.2 M (↑101% YoY); gross profit margin 8.2% of sales.
  • Quarterly EBITDA: $(0.7) M (loss), impacted by currency‑hedge derivative losses.
  • Nine‑Month Sales: $45.9 M, up 222% YoY; already 122% greater than FY2024 total ($20.7 M).
  • Nine‑Month Gross Profit: $3.6 M (↑208% YoY); gross profit margin 7.7% of sales.
  • Nine‑Month EBITDA: $(0.9) M (loss), also affected by derivative losses.
  • Net Loss Q3: $2.0 M (includes $0.4 M interest/acc. costs, $0.4 M derivative loss, $0.1 M debt restructuring cost, $1.7 M debt settlement loss).
  • Net Loss Nine‑Month: $9.6 M (includes $0.6 M interest/acc. costs, $2.3 M derivative loss, $0.8 M debt restructuring cost, $5.5 M debt settlement loss).
  • Cash Position: $8.8 M (excluding restricted cash) vs. $0.3 M at 12‑31‑2024.
  • Working Capital: $8.6 M vs. –$14.6 M at 12‑31‑2024.
  • Debt Reduction: Short‑term loans & convertible debentures down to $2.5 M from $12.5 M (12‑31‑2024).
  • Warrant Exercise: June 2025 private placement issued 4,000,000 units @ $0.25/unit ($1.0 M gross). Holders exercised half‑share warrants for 1,000,000 common shares at $0.35/share, generating $350,000 cash; shares released from hold period on 27‑Oct‑2025.

Notable Quotes

  • “These results are the outcome of the extensive restructuring and business realignment we've executed over the past 21 months… we believe sets a solid foundation for sustained growth, stability, and a clear path to profitability.” – Steve Bromley, Co‑Chair & CEO

Materiality Assessment: Material – Neutral (significant financial performance and balance‑sheet changes disclosed).

Read the original news release →

More from Organto Foods Inc.